Patents for A61P 35 - Antineoplastic agents (221,099)
07/1994
07/21/1994WO1994016069A2 Ras associated gap proteins
07/21/1994WO1994015966A1 Growth differentiation factor-9
07/21/1994WO1994015965A1 Growth differentiation factor-3
07/21/1994WO1994015958A2 Peptide inhibitors of cell adhesion
07/21/1994WO1994015949A1 Growth differentiation factor-5
07/21/1994WO1994015929A1 Process for the preparation of 10-desacetoxybaccatin iii
07/21/1994WO1994015912A1 New crystalline form of a vitamin d analogue
07/21/1994WO1994015902A1 Compounds having selectivity for retinoid x receptors
07/21/1994WO1994015898A1 Dehydrogenation processes and equipment therefor
07/21/1994WO1994015642A1 Methods of delivering agents to target cells
07/21/1994WO1994015641A1 Method for modulating transendothelial migration of cells promoting inflammation, and related methods of measurement thereof
07/21/1994WO1994015635A1 Inducing cytotoxic t lymphocyte responses
07/21/1994WO1994015619A1 OLIGONUCLEOTIDES MODIFIED TO IMPROVE STABILITY AT ACID pH
07/21/1994WO1994015615A1 Potentiation of temozolomide in human tumour cells
07/21/1994WO1994015604A1 Transdermal treatment of cancer with water-insoluble s-camptothecin of the closed lactone ring form
07/21/1994WO1994015599A1 C10 taxane derivatives and pharmaceutical compositions
07/21/1994WO1994007479A3 Immunopotentiatory agents
07/21/1994CA2153776A1 Method for modulating transendothelial migration of cells promoting inflammation, and related methods of measurement thereof
07/21/1994CA2153654A1 Growth differentiation factor-5
07/21/1994CA2153652A1 Growth differentiation factor-3
07/21/1994CA2153568A1 Methods of delivering agents to target cells
07/21/1994CA2153486A1 Ras associated gap proteins
07/21/1994CA2153228A1 Peptide inhibitors of cell adhesion
07/21/1994CA2152672A1 Oligomers having improved stability at acid ph
07/21/1994CA2094796A1 N-methyldeacetylcolchiceinamide derivatives
07/20/1994EP0607054A2 Novel process for constructing a cDNA library and a novel polypeptide and DNA coding the same
07/20/1994EP0606723A1 Imidazolidin-2-one derivatives and their use as antitumor agents
07/20/1994EP0606222A1 Cyclic hexapeptides as tachyquinin antagonists, their preparation and pharmaceutical compositions thereof
07/20/1994EP0606217A1 Ctl4a receptor, fusion proteins containing it and uses thereof
07/20/1994CN1089608A Imidazopyridines
07/20/1994CN1089603A Novel pyridine-2-carboxylase and pyridine-N-oxide and preparation and pharmaceutical use of same
07/20/1994CN1089599A Derivative of vitamin D system which is modified in 20-position, preparation of same and pharmaceutical made of same
07/20/1994CN1089505A Novel pharmaceutical application of nonimmunogenproteinic material and composition
07/20/1994CA2113658A1 Isolation and elucidation of cephalostatin 7, 8 and 9
07/20/1994CA2113657A1 Isolation and structure of hallistatin 2
07/20/1994CA2113655A1 Isolation and structure of hallistatin 1
07/19/1994US5331014 Effect of N,N,N-trimethylsphingosine on protein kinase-C activity; melanoma cell growth in vitro; metastatic potential in vivo and human platelet aggregation
07/19/1994US5330977 Di-N-acetyl lysoganglioside compositions
07/19/1994CA1330793C Platinum pharmaceuticals
07/15/1994CA2381458A1 Process for constructing a cdna library and a novel polypeptide and dna coding the same
07/13/1994EP0606175A1 2-Cyano-3-hydroxypropenamide derivatives, process for their preparation, their use as medicaments and pharmaceutical compositions containing them
07/13/1994EP0606046A1 Arylsulfonamido-substituted hydroxamic acids
07/13/1994EP0606012A1 Compositions containing cholesteryl esters of unsaturated fatty acids
07/13/1994EP0605753A1 Cyclodextrin inclusion complex of taxol, and method for its production and its use
07/13/1994EP0605682A1 Peptidyl derivatives and their use as metalloproteinases inhibitors
07/13/1994EP0605681A1 Sulphamide derivatives as metalloproteinase inhibitors
07/13/1994EP0605582A1 Phosphoramidate analogs of 5-fluoro-2'-deoxyuridine
07/13/1994EP0605522A1 Production of chimeric antibodies - a combinatorial approach
07/13/1994EP0605466A1 Method and compositions for cellular reprogramming
07/13/1994EP0327640B1 Immunotherapeutic compositions for the treatment of acquired immune deficiency syndrome
07/13/1994CN1089137A Injectable mesna solutions
07/12/1994US5329048 Reaction of tert-butyloxycarbonylaniline with 1,1' carbonyl diimidazole then ethylenediamine, then acidification to remove tert-butyloxycarbonyl
07/12/1994US5329012 Bis(acyloxmethyl)imidazole compounds
07/12/1994US5328929 Isolation and structure of spongistatin 2, spongistatin 3, spongistatin 4 and spongistatin 6
07/12/1994US5328909 Cyclopropenone derivatives
07/12/1994US5328907 4-isoxazolecarboxamide derivatives
07/12/1994US5328470 Catheter
07/07/1994WO1994014959A1 New protein from urine named component b
07/07/1994WO1994014845A1 Modified tcf
07/07/1994WO1994014843A1 Endothelin antagonists
07/07/1994WO1994014829A1 Etoposide derivatives, process for their preparation, their use as a drug and in the preparation of a drug for treating cancer
07/07/1994WO1994014808A1 Vinylene-azaindole derivatives and process for their preparation
07/07/1994WO1994014798A1 Aminoacid derivatives of heterocycles as protein kinase c inhibitors
07/07/1994WO1994014787A1 Novel sidechain-bearing taxanes and intermediates thereof
07/07/1994WO1994014777A1 Heterocyclic carbonic acid derivatives which bind to retinoid receptors (rar)
07/07/1994WO1994014766A1 Novel vitamin d analogues
07/07/1994WO1994014448A1 Novel combination of benzoquinazoline antifolates and protecting agents
07/07/1994WO1994014436A1 Retroviral protease inhibiting compounds
07/07/1994WO1994011509A3 Peptides and anti-sense peptides with broad neoplastic specificity
07/07/1994WO1994011502A3 Activin receptor-like kinases, proteins having serine threonine kinase domains and their use
07/07/1994EP0642503A4 10-desacetoxytaxol derivatives.
07/07/1994CA2152270A1 Etoposide derivatives; process for preparing the same and their use as drugs and for preparing an anticancer drug
07/07/1994CA2151156A1 New protein from urine named component b
07/07/1994CA2146874A1 Endothelin antagonists
07/07/1994CA2130561A1 Modified tcf
07/07/1994CA2129846A1 Heterocyclic carbonic acid derivatives which bind to retinoid receptors (rar)
07/07/1994CA2126228A1 Vinylene-azaindole derivatives and process for their preparation
07/07/1994CA2112824A1 Compositions containing esters of unsaturated fatty acids
07/06/1994EP0605078A1 5,6,7,9-Tetrahydro-1,2,3-trimethoxy-9-oxobenzo alpha heptalene derivative
07/06/1994EP0604910A1 Phosphonooxymethyl ethers of taxane derivatives
07/06/1994EP0604800A1 4- 4- 4-(carboxyalkyl)-phenyl amino carbonyl -phenyl -piperedines as aggregation inhibitors
07/06/1994EP0604603A1 Cadherin materials and methods
07/06/1994EP0515540B1 Derivative of beta-phenylisoserine, preparation and utilisation thereof
07/06/1994EP0324788B1 Peptide fragment capable of binding to laminin
07/06/1994CN1088911A 5,6,7,9-tetrahydro-1,2,3-trimethoxy-9-oxobenzoÛalphaÙheptalene derivative
07/06/1994CN1025334C Process for preparing glutamic acid derivs.
07/06/1994CN1025332C Method for preparing thiochroman esters of phenols and terephthallates having retinoid-like activity
07/05/1994US5326905 Benzylphosphonic acid tyrosine kinase inhibitors
07/05/1994US5326898 Substituted phenylethenyl compounds having retinoid-like biological activity
07/05/1994US5326786 5,6,7,9-tetrahydro-1,2,3-trimethoxy-9-oxobenzo[alpha]heptalene derivative and pharmaceutical use
07/05/1994US5326773 Prodrug enzyme inhibitors
07/05/1994CA1330567C Tetralin esters of phenols or benzoic acids having retinoid like activity
07/05/1994CA1330560C Di- and tetrahydroisoquinoline derivatives
06/1994
06/30/1994CA2605872A1 Intermediates for retroviral protease inhibiting compounds
06/29/1994EP0604301A1 p-Di[2-chloroethyl)amino]phenylalanine derivatives process for their preparation and pharmaceutical compositions containing them
06/29/1994EP0604181A1 Antitumor compositions and method of treatment
06/29/1994EP0604143A2 Rapamycin loaded formed blood elements to induce immunosuppression
06/29/1994EP0603769A1 Alpha-Aminoketone derivatives
06/29/1994EP0603735A2 Monoclonal antibodies that define a unique antigen of human B-cell antigen receptor complex
06/29/1994EP0603650A1 3,5-Substituted amino benzoylguanidines, process for their preparation, their use as medicine or diagnostic agent, as well as a medicine containing them